Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRANASDAQ

Lyra Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Maria Palasis, with a market cap of $6.5M. As of Q3 2025, 27% of shares are held by 25 institutional investors, with PERCEPTIVE ADVISORS LLC as the largest holder at 13.95%.

President and Chief Executive OfficerMaria Palasis
Market Cap$6.5M
Biotechnology
Healthcare
Employees109.0
Country
United States of America

Overview

Overview of institutional ownership in LYRA as of Q3 2025 with a market cap of $10.7M

All Institutions

Institutions
25
Value Held
$2.9M
Shares Held
448.6K
Avg Position
$117.3K
Median Position
$2.7K

Hedge Funds

Hedge Funds
3
Value Held
$1.8M
Shares Held
270.0K
Avg Position
$588.6K
Median Position
$139.5K

Ownership Breakdown

Institutional (non-HF): 10.88%Institutional (non-HF)Hedge Funds: 16.45%Hedge FundsRetail & Other: 72.66%Retail & Other
Institutional (non-HF)
10.88%
$1.2M
Hedge Funds
16.45%
$1.8M
Retail & Other
72.66%
$7.8M

Based on market cap of $10.7M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in LYRA as of Q3 2025

InstitutionPosition Value
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
$1.5M
0.04% of portfolio
$832.9K
4.53% of portfolio
$189.5K
0.00% of portfolio
Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
$139.5K
0.03% of portfolio
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$128.4K
0.00% of portfolio
$72.4K
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$26.1K
0.00% of portfolio
B
BlackRock, Inc.
Institution
$11.0K
0.00% of portfolio
$8.6K
0.00% of portfolio
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$8.3K
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for LYRA in Q3 2025

Traded
$136.6K
Buyers
10
Sellers
17
Total Bought
+$170.6K
Total Sold
$307.3K
Avg Position
$86.3K

Biggest Buyers

InstitutionNet Bought
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$128.4K
+19.5K shares
UBS Group AG logo
UBS Group AG
Institution
+$26.1K
+4.0K shares
+$12.4K
+1.9K shares
+$1.5K
+223.0 shares
+$1.3K
+200.0 shares
+$627.0
+96.0 shares
+$143.0
+22.0 shares
+$131.0
+20.0 shares
+$117.0
+-28.5K shares
+$13.0
+-304.0 shares

Biggest Sellers

InstitutionNet Sold
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
$168.3K
25.8K shares
$94.1K
10.5K shares
$14.3K
1.6K shares
FMR LLC logo
FMR LLC
Institution
$8.8K
1.3K shares
$6.2K
949.0 shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$5.8K
887.0 shares
$4.5K
500.0 shares
$2.8K
424.0 shares
$1.1K
165.0 shares
CITIGROUP INC logo
CITIGROUP INC
Institution
$593.1
90.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited LYRA in Q3 2025

New Positions
1
New Value
$627.0
Exited Positions
8
Exited Value
$113.5K

New Positions

InstitutionPosition Value
$627.0
96.0 shares

Exited Positions

InstitutionPrevious Position
$94.1K
10.5K shares
$14.3K
1.6K shares
$4.5K
500.0 shares
$349.0
39.0 shares
$170.0
19.0 shares
$90.0
10.0 shares
$72.0
8.0 shares
BARCLAYS PLC logo
BARCLAYS PLC
Institution
-
48.0 shares

Options Activity

Institutions with the largest Call and Put options positions in LYRA as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with LYRA as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
4.53%
$832.9K
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
0.04%
$1.5M
Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
0.03%
$139.5K
0.00%
$2.6K
0.00%
$627.0
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
0.00%
$128.4K
0.00%
$3.5K
0.00%
$2.3K
0.00%
$522.0
UBS Group AG logo
UBS Group AG
Institution
0.00%
$26.1K

Hedge Fund Spotlight

Discover hedge funds investing in LYRA

CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
Portfolio ManagerKenneth Cordele Griffin
Portfolio Value
$122.08B
Positions
5,531
Last Reported
Q3 2025
AddressMiami, FL
Sector Allocation
Technology: 19.30%TechnologyHealthcare: 13.00%HealthcareFinancial Services: 12.00%Financial ServicesIndustrials: 10.80%IndustrialsConsumer Cyclical: 10.30%Consumer CyclicalConsumer Defensive: 5.70%ETF: 5.70%Communication Services: 4.90%Real Estate: 3.40%Energy: 3.30%Basic Materials: 3.00%Utilities: 2.70%
Lyra Therapeutics, Inc. logo

Position in Lyra Therapeutics, Inc.

Market Value
$128.4K
Shares Held
19.5K
Portfolio Weight
0.00%
Owned Since
2022-Q3
Top HoldingSectorMarket ValueWeight
Software - Infrastructure
Technology
$2.1B1.68%
2
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$1.8B1.50%
Internet Content & Information
Communication Services
$1.4B1.18%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.